• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21959 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2001     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical effectiveness and cost utility of photodynamic therapy for age-related macular degeneration
2006     West Midlands Health Technology Assessment Collaboration (WMHTAC) Effects of oily fish/omega-3 fatty acids on the behavioural, cognitive and educational outcomes of normal school children: a systematic review
2006     West Midlands Health Technology Assessment Collaboration (WMHTAC) Mapping the evidence base and use of acupuncture within the NHS
2006     West Midlands Health Technology Assessment Collaboration (WMHTAC) Acupuncture for allergic rhinitis
2006     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost effectiveness of counselling interventions for heavy alcohol drinkers to reduce domestic violence
2003     West Midlands Health Technology Assessment Collaboration (WMHTAC) The impact of the emotional disclosure intervention on physical and psychological health - a systematic review
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Air travel as a risk factor for venous thromboembolism (VTE) and the effectiveness of preventive measures
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Expandable metal stents for inoperable oesophageal cancer
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Fludarabine as first line therapy for chronic lymphocytic leukaemia
2004     West Midlands Health Technology Assessment Collaboration (WMHTAC) A systematic review of effectiveness and cost effectiveness of tacrolimus ointment for topical treatment of atopic dermatitis in adults and children
2004     West Midlands Health Technology Assessment Collaboration (WMHTAC) Influenza vaccination of health care workers (HCW) to reduce influenza-related outcomes in high risk patients: a systematic review of clinical and cost-effectiveness
2004     West Midlands Health Technology Assessment Collaboration (WMHTAC) Systematic review of clinical effectiveness and cost-effectiveness of radiofrequency ablation for the treatment of varicose veins
2010     West Midlands Health Technology Assessment Collaboration (WMHTAC) Interventions to improve the prescribing of antibiotics by healthcare professionals in ambulatory care settings
2009     West Midlands Health Technology Assessment Collaboration (WMHTAC) A systematic review of lesbian, gay, bisexual and transgender health in the West Midlands region of the UK compared to published UK research
2008     West Midlands Health Technology Assessment Collaboration (WMHTAC) Mapping the evidence base and use of neurostimulators
2006     West Midlands Health Technology Assessment Collaboration (WMHTAC) Simple interventions to prevent respiratory and gastrointestinal infection in children in day care and school settings - a systematic review and economic evaluation
2000     West Midlands Health Technology Assessment Collaboration (WMHTAC) Antiretroviral therapy for HIV infection in patients naive to prior treatment: a systematic review of effectiveness and cost-effectiveness
2004     West Midlands Health Technology Assessment Collaboration (WMHTAC) Behavioural interventions to reduce the risk of sexually transmitted infections in genitourinary medicine clinic patients: a systematic review
2003     West Midlands Health Technology Assessment Collaboration (WMHTAC) Local nurse telephone triage in primary care
1998     West Midlands Health Technology Assessment Collaboration (WMHTAC) The use of olanzapine as a first and second choice treatment in schizophrenia
1999     West Midlands Health Technology Assessment Collaboration (WMHTAC) Lung volume reduction surgery for chronic obstructive pulmonary disease with underlying severe emphysema
1998     West Midlands Health Technology Assessment Collaboration (WMHTAC) Coronary artery stents in the treatment of ischaemic heart disease
1996     Wessex Institute for Health Research and Development (WIHRD) Ceredase in the treatment of type 1 Gaucher's disease
1996     Wessex Institute for Health Research and Development (WIHRD) Cognitive behavioural therapy in the treatment of chronic fatigue syndrome
1996     Wessex Institute for Health Research and Development (WIHRD) Pallidotomy for Parkinson's disease
1996     Wessex Institute for Health Research and Development (WIHRD) Alpha interferon in the treatment of chronic myeloid leukaemia
1996     Wessex Institute for Health Research and Development (WIHRD) Prestorage filtration of blood components for patients who are chronically transfusion dependent
1996     Wessex Institute for Health Research and Development (WIHRD) Goserelin or other gonadotrophin releasing hormone (GnRH) analogues in the treatment of advanced prostate cancer
1996     Wessex Institute for Health Research and Development (WIHRD) Implantable infusion devices (IIPs) for long-term pain management
1996     Wessex Institute for Health Research and Development (WIHRD) Paclitaxel as a first line chemotherapy agent in the treatment of ovarian cancer
1996     Wessex Institute for Health Research and Development (WIHRD) Growth hormone in children (for growth hormone deficiency, Turner's syndrome, chronic renal failure and idiopathic short stature)
1996     Wessex Institute for Health Research and Development (WIHRD) Factor V Leiden screening in oral contraceptive users
1996     Wessex Institute for Health Research and Development (WIHRD) 5-fluorouracil (5-FU) as adjuvant chemotherapy in Duke's stage C colorectal cancer
1996     Wessex Institute for Health Research and Development (WIHRD) Extracorporeal membrane oxygenation for term neonates with severe respiratory failure
1996     Wessex Institute for Health Research and Development (WIHRD) Screening for hepatitis B in pregnancy
1996     Wessex Institute for Health Research and Development (WIHRD) Laser trabeculoplasty as primary therapy for glaucoma
1996     Wessex Institute for Health Research and Development (WIHRD) Copolymer 1 in relapsing-remitting multiple sclerosis
1996     Wessex Institute for Health Research and Development (WIHRD) Zafirlukast (Accolate) in asthma
1996     Wessex Institute for Health Research and Development (WIHRD) Evening primrose oil for cyclical mastalgia
1997     Wessex Institute for Health Research and Development (WIHRD) Auditory integration training in autism
1997     Wessex Institute for Health Research and Development (WIHRD) The therapeutic community method of treatment for borderline personality disorder
1997     Wessex Institute for Health Research and Development (WIHRD) Gastroplasty for severe obesity
1997     Wessex Institute for Health Research and Development (WIHRD) Donepezil in the treatment of mild to moderate senile dementia of the Alzheimer type (SDAT)
1997     Wessex Institute for Health Research and Development (WIHRD) In-patient vs out-patient pain management programmes that adopt a cognitive behavioural approach
1997     Wessex Institute for Health Research and Development (WIHRD) On-demand recombinant factor VIII for people with haemophilia A
1997     Wessex Institute for Health Research and Development (WIHRD) HMG CO-A reductase inhibitor treatment in the prevention of coronary heart disease
2001     Wessex Institute for Health Research and Development (WIHRD) Microdiscectomy for prolapsed intervertebral disc
1997     Wessex Institute for Health Research and Development (WIHRD) Riluzole for motor neurone disease
2001     Wessex Institute for Health Research and Development (WIHRD) Cryotherapy for prostatic cancer
1997     Wessex Institute for Health Research and Development (WIHRD) Tacrolimus after kidney transplantation
2001     Wessex Institute for Health Research and Development (WIHRD) Spinal cord stimulation for chronic pain
1997     Wessex Institute for Health Research and Development (WIHRD) Growth hormone for growth hormone deficient adults
2001     Wessex Institute for Health Research and Development (WIHRD) Osteo-odonto-keratoprosthesis as a treatment for severe corneal opacities
1997     Wessex Institute for Health Research and Development (WIHRD) Screening staff for methicillin resistant Staphylococcus aureus (MRSA)
2001     Wessex Institute for Health Research and Development (WIHRD) Thermal laser photocoagulation for age related macular degeneration
1997     Wessex Institute for Health Research and Development (WIHRD) Interferon beta-1a in relapsing-remitting multiple sclerosis
2001     Wessex Institute for Health Research and Development (WIHRD) Hip resurfacing in younger people with osteoarthritis
1998     Wessex Institute for Health Research and Development (WIHRD) Methylphenidate in children with hyperactivity
2001     Wessex Institute for Health Research and Development (WIHRD) Effects of desensitisation treatments and clinical ecology for multiple chemical sensitivity and related disorders
1998     Wessex Institute for Health Research and Development (WIHRD) Bisphosphonates (alendronate and etidronate) in the management of osteoporosis
2001     Wessex Institute for Health Research and Development (WIHRD) Photodynamic phototherapy (including verteporfin) for neovascular age related macular degeneration
1998     Wessex Institute for Health Research and Development (WIHRD) Lamotrigine as monotherapy for epilepsy in adults
2001     Wessex Institute for Health Research and Development (WIHRD) Laparoscopic ablation or resection of endometriosis deposits for moderate and severe endometriosis
1998     Wessex Institute for Health Research and Development (WIHRD) Screening for hepatitis C in intravenous drug users and genito-urinary clinic attendees
2001     Wessex Institute for Health Research and Development (WIHRD) Repeat inpatient rehabilitation for people with relapsed alcohol addiction
1998     Wessex Institute for Health Research and Development (WIHRD) Vagus nerve stimulation in epilepsy
2001     Wessex Institute for Health Research and Development (WIHRD) Stereotactic radiosurgery for brain tumours and arteriovenous malformations
1998     Wessex Institute for Health Research and Development (WIHRD) Tinnitus retraining therapy
2001     Wessex Institute for Health Research and Development (WIHRD) Pre- and peri-operative antibiotic prophylaxis for colorectal surgery
1998     Wessex Institute for Health Research and Development (WIHRD) The use of olanzapine as a first and second choice treatment in schizophrenia
2001     Wessex Institute for Health Research and Development (WIHRD) Pre-implantation diagnosis
2001     Wessex Institute for Health Research and Development (WIHRD) Functional electrical stimulation for limb motor dysfunction following stroke
2001     Wessex Institute for Health Research and Development (WIHRD) Brachytherapy for localised prostate cancer
2001     Wessex Institute for Health Research and Development (WIHRD) Surgical interventions for morbid obesity
2001     Wessex Institute for Health Research and Development (WIHRD) Effects of TNF-alpha antagonists in people with rheumatoid arthritis
2001     Wessex Institute for Health Research and Development (WIHRD) Ambulatory versus conventional blood pressure monitoring
2002     Wessex Institute for Health Research and Development (WIHRD) Growth hormone replacement therapy for adults with growth hormone deficiency
2002     Wessex Institute for Health Research and Development (WIHRD) Immunotherapy for seasonal rhinitis, asthma and bee sting venom allergy
2002     Wessex Institute for Health Research and Development (WIHRD) Cox-II inhibitors versus non-steroidal anti-inflammatory drugs in rheumatoid and osteoarthritis patients: gastrointestinal effects
2002     Wessex Institute for Health Research and Development (WIHRD) Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-Alzheimer's dementia
2002     Wessex Institute for Health Research and Development (WIHRD) Pre-operative delay after femoral fracture
2002     Wessex Institute for Health Research and Development (WIHRD) Insulin pumps, conventional and intensive multiple injection insulin therapy for type 1 diabetes mellitus
2002     Wessex Institute for Health Research and Development (WIHRD) Outpatient physiotherapy services for low back pain
2002     Wessex Institute for Health Research and Development (WIHRD) Update report: Non-myeloablative bone marrow and peripheral blood stem cell transplant
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for multiple sclerosis
2002     Wessex Institute for Health Research and Development (WIHRD) Lung volume reduction surgery for diffuse emphysema
2002     Wessex Institute for Health Research and Development (WIHRD) Selective denervation for spasmodic torticollis
2002     Wessex Institute for Health Research and Development (WIHRD) Imatinib for gastrointestinal stromal tumours
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for carbon monoxide poisoning
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy in people with necrotising fasciitis or Fournier's gangrene
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for central retinal artery occlusion
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for central osteoradionecrosis
2002     Wessex Institute for Health Research and Development (WIHRD) Immediate versus delayed breast reconstruction
1999     Wessex Institute for Health Research and Development (WIHRD) Reducing the interval for diabetic retinal screening
2003     Wessex Institute for Health Research and Development (WIHRD) Cosmetic breast augmentation
2000     Wessex Institute for Health Research and Development (WIHRD) Dalteparin and enoxaparin for unstable angina and non-Q-wave myocardial infarction: update
2003     Wessex Institute for Health Research and Development (WIHRD) Outcomes of abdominoplasty
2003     Wessex Institute for Health Research and Development (WIHRD) Arthroscopic lavage for knee osteoarthritis
2003     Wessex Institute for Health Research and Development (WIHRD) Sympathectomy for facial blushing
2003     Wessex Institute for Health Research and Development (WIHRD) Coil embolisation of ruptured or unruptured intracranial aneurysms